{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T17:25:30Z","timestamp":1785173130656,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011110","name":"UCB","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011110","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012112","name":"Sobi","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012112","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Clinics of North America"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.pcl.2018.03.005","type":"journal-article","created":{"date-parts":[[2018,7,19]],"date-time":"2018-07-19T23:23:12Z","timestamp":1532042592000},"page":"657-674","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Juvenile Idiopathic Arthritis"],"prefix":"10.1016","volume":"65","author":[{"given":"Courtney B.","family":"Crayne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Beukelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.pcl.2018.03.005_bib1","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.pcl.2018.03.005_bib2","series-title":"Textbook of pediatric rheumatology","author":"Petty","year":"2016"},{"issue":"2","key":"10.1016\/j.pcl.2018.03.005_bib3","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.pcl.2012.03.014","article-title":"Juvenile idiopathic arthritis","volume":"59","author":"Gowdie","year":"2012","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.pcl.2018.03.005_bib4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jaut.2014.01.009","article-title":"Diagnosis and classification of juvenile idiopathic arthritis","volume":"48-49","author":"Eisenstein","year":"2014","journal-title":"J\u00a0Autoimmun"},{"issue":"6","key":"10.1016\/j.pcl.2018.03.005_bib5","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1002\/art.22709","article-title":"Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort: ethnicity as a risk factor","volume":"56","author":"Saurenmann","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pcl.2018.03.005_bib6","first-page":"379","article-title":"Polyarticular juvenile idiopathic arthritis - epidemiology and management approaches","volume":"6","author":"Oberle","year":"2014","journal-title":"Clin Epidemiol"},{"issue":"9","key":"10.1016\/j.pcl.2018.03.005_bib7","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.3899\/jrheum.111441","article-title":"Risk factors for temporomandibular joint arthritis in children with juvenile idiopathic arthritis","volume":"39","author":"Stoll","year":"2012","journal-title":"J\u00a0Rheumatol"},{"issue":"5","key":"10.1016\/j.pcl.2018.03.005_bib8","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/BOR.0000000000000316","article-title":"Uveitis in children","volume":"28","author":"Angeles-Han","year":"2016","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"10.1016\/j.pcl.2018.03.005_bib9","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/rheumatology\/kem053","article-title":"Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines","volume":"46","author":"Heiligenhaus","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.pcl.2018.03.005_bib10","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.survophthal.2015.06.004","article-title":"Anti-tumor necrosis factor-alpha therapy in uveitis","volume":"60","author":"Cordero-Coma","year":"2015","journal-title":"Surv Ophthalmol"},{"issue":"17","key":"10.1016\/j.pcl.2018.03.005_bib11","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa1614160","article-title":"Adalimumab plus methotrexate for uveitis in juvenile idiopathic arthritis","volume":"376","author":"Ramanan","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.pcl.2018.03.005_bib12","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s00296-014-3022-2","article-title":"Growth abnormalities in children and adolescents with juvenile idiopathic arthritis","volume":"34","author":"Bechtold","year":"2014","journal-title":"Rheumatol Int"},{"issue":"12","key":"10.1016\/j.pcl.2018.03.005_bib13","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1093\/rheumatology\/41.12.1428","article-title":"Long-term follow-up of 246 adults with juvenile idiopathic arthritis: functional outcome","volume":"41","author":"Packham","year":"2002","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.pcl.2018.03.005_bib14","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jcms.2016.01.014","article-title":"Juvenile idiopathic arthritis and the temporomandibular joint: a comprehensive review","volume":"44","author":"El Assar de la Fuente","year":"2016","journal-title":"J\u00a0Craniomaxillofac Surg"},{"issue":"11","key":"10.1016\/j.pcl.2018.03.005_bib15","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1136\/annrheumdis-2015-207892","article-title":"EULAR-PReS points to consider for the use of imaging in the diagnosis and management of juvenile idiopathic arthritis in clinical practice","volume":"74","author":"Colebatch-Bourn","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.pcl.2018.03.005_bib16","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jbspin.2012.03.008","article-title":"Anti-cyclic citrullinated peptide (anti-CCP) antibody in juvenile idiopathic arthritis (JIA): correlations with disease activity and severity of joint damage (a multicenter trial)","volume":"80","author":"Omar","year":"2013","journal-title":"Joint Bone Spine"},{"issue":"1","key":"10.1016\/j.pcl.2018.03.005_bib17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1546-0096-10-29","article-title":"Profiling anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis","volume":"10","author":"Tebo","year":"2012","journal-title":"Pediatr Rheumatol Online J"},{"issue":"4","key":"10.1016\/j.pcl.2018.03.005_bib18","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/acr.20460","article-title":"2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features","volume":"63","author":"Beukelman","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"10.1016\/j.pcl.2018.03.005_bib19","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1136\/annrheumdis-2011-201264","article-title":"Ultrasound-detected synovial abnormalities are frequent in clinically inactive juvenile idiopathic arthritis, but do not predict a flare of synovitis","volume":"72","author":"Magni-Manzoni","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.pcl.2018.03.005_bib20","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/acr.20497","article-title":"American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis","volume":"63","author":"Wallace","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.pcl.2018.03.005_bib21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1546-0096-12-13","article-title":"Treatment of juvenile idiopathic arthritis: a revolution in care","volume":"12","author":"Stoll","year":"2014","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"10.1016\/j.pcl.2018.03.005_bib22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrrheum.2016.178","article-title":"Adenosine and adenosine receptors in the pathogenesis and treatment of rheumatic diseases","volume":"13","author":"Cronstein","year":"2017","journal-title":"Nat Rev Rheumatol"},{"issue":"16","key":"10.1016\/j.pcl.2018.03.005_bib23","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1056\/NEJM199204163261602","article-title":"Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group","volume":"326","author":"Giannini","year":"1992","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.pcl.2018.03.005_bib24","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12969-017-0180-2","article-title":"Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis","volume":"15","author":"Falvey","year":"2017","journal-title":"Pediatr Rheumatol Online J"},{"issue":"16","key":"10.1016\/j.pcl.2018.03.005_bib25","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMoa041810","article-title":"Leflunomide or methotrexate for juvenile rheumatoid arthritis","volume":"352","author":"Silverman","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.pcl.2018.03.005_bib26","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.rdc.2013.05.004","article-title":"Treatment of juvenile idiopathic arthritis in the biologic age","volume":"39","author":"Stoll","year":"2013","journal-title":"Rheum Dis Clin North Am"},{"issue":"5","key":"10.1016\/j.pcl.2018.03.005_bib27","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/1529-0131(199805)41:5<808::AID-ART6>3.0.CO;2-T","article-title":"Sulfasalazine in the treatment of juvenile chronic arthritis: a randomized, double-blind, placebo-controlled, multicenter study. Dutch Juvenile Chronic Arthritis Study Group","volume":"41","author":"van Rossum","year":"1998","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.pcl.2018.03.005_bib28","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1056\/NEJM200003163421103","article-title":"Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group","volume":"342","author":"Lovell","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.pcl.2018.03.005_bib29","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/art.23427","article-title":"Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis","volume":"58","author":"Lovell","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.pcl.2018.03.005_bib30","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa0706290","article-title":"Adalimumab with or without methotrexate in juvenile rheumatoid arthritis","volume":"359","author":"Lovell","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.pcl.2018.03.005_bib31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/annrheumdis-2016-210456","article-title":"Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trial","volume":"77","author":"Brunner","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.pcl.2018.03.005_bib32","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1136\/annrheumdis-2014-205351","article-title":"Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial","volume":"74","author":"Brunner","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"25","key":"10.1016\/j.pcl.2018.03.005_bib33","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMoa1112802","article-title":"Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis","volume":"367","author":"De Benedetti","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"9636","key":"10.1016\/j.pcl.2018.03.005_bib34","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0140-6736(08)60998-8","article-title":"Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial","volume":"372","author":"Ruperto","year":"2008","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.pcl.2018.03.005_bib35","first-page":"1268","article-title":"Factors influencing the economics of biosimilars in the US","volume":"20","author":"Mehr","year":"2017","journal-title":"J\u00a0Med Econ"},{"issue":"3","key":"10.1016\/j.pcl.2018.03.005_bib36","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.semarthrit.2017.05.007","article-title":"How common is remission in juvenile idiopathic arthritis: a systematic review","volume":"47","author":"Shoop-Worrall","year":"2017","journal-title":"Semin Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.pcl.2018.03.005_bib37","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1136\/annrheumdis-2014-205372","article-title":"The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort","volume":"74","author":"Guzman","year":"2015","journal-title":"Ann Rheum Dis"}],"container-title":["Pediatric Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395518300385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395518300385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T21:10:50Z","timestamp":1589922650000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031395518300385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0031395518300385"],"URL":"https:\/\/doi.org\/10.1016\/j.pcl.2018.03.005","relation":{},"ISSN":["0031-3955"],"issn-type":[{"value":"0031-3955","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Juvenile Idiopathic Arthritis","name":"articletitle","label":"Article Title"},{"value":"Pediatric Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcl.2018.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}